sorafenib has been researched along with Cognitive Decline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, YQ; Li, DJ; Ni, CX; Qiu, YS; Shen, FM; Zhou, CC | 1 |
1 other study(ies) available for sorafenib and Cognitive Decline
| Article | Year |
|---|---|
Zinc supplementation ameliorates sorafenib-induced cognitive impairment through ROS/JNK signaling pathway.
Topics: Animals; Anisomycin; Apoptosis; Cell Line, Tumor; Cognitive Dysfunction; Dietary Supplements; Humans; MAP Kinase Signaling System; Mice; Neuroblastoma; Oxidative Stress; Reactive Oxygen Species; Sorafenib; Zinc | 2023 |